Search

everythinglearnresearchcommunity

for

Search:↓

A substance called 15-deoxy prostaglandin J2 can cause hair follicle cells to die, which might explain how prostaglandin D2 can lead to hair loss.

A substance called prostaglandin D2 is found more in bald scalps and it stops hair from growing. Blocking its receptor could potentially treat hair loss.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth, suggesting that blocking its receptor could potentially treat hair loss.

Higher levels of the DP2 receptor may lead to hair loss.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, and antioxidants may help treat hair loss.

PGD2 stops hair growth and is higher in bald men with AGA.

Different human hair follicle stem cells grow at different rates and respond differently to a baldness-related compound.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth and could be a target for treating hair loss.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

Topical cetirizine improves hair density and thickness in androgenetic alopecia, but more research is needed.

Conflicting findings in androgenic alopecia are likely due to biopsy location, hair diameter diversity, and hair follicle miniaturization.

Targeting the PGD2-DP2 pathway may help treat hair loss.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

Western diet may cause male pattern baldness; low glycemic diet with magnesium could help.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Hair restoration surgery effectively treats hair loss with natural-looking results, using techniques like stem cells and platelet-rich plasma.

Morroniside may help hair grow and stay in its growth phase by affecting certain cell signals.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

New physical methods like electrical currents, ultrasound, and microneedles show promise for improving drug delivery through the skin.